South Korea's medicine-safety system is led by the Ministry of Food and Drug Safety (MFDS), with adverse-event collection and safety-information infrastructure supported by the Korea Institute of Drug Safety & Risk Management.
Core official resources
- MFDS β national regulator for medicines and the primary source for safety regulations, notices and guidance.
- MFDS medicines-safety reporting policy material β official policy material addressing medicines-safety information reporting and adverse-event reporting considerations.
- Drug Safety Information Portal β medicines safety and adverse-event information portal operated through the national drug-safety infrastructure.
Practical use
Search MFDS by the Korean terms for pharmacovigilance (μ½λ¬Όκ°μ), adverse events (μ΄μμ¬λ‘) and risk management plan (μν΄μ± κ΄λ¦¬ κ³ν). Product-specific RMP obligations and post-marketing surveillance requirements should be checked against the current MFDS approval conditions and notices.